Former Chief Scientific Officer(11) · Korro Bio, Inc. (KRRO)

Christopher Loose

A named executive officer of Korro Bio in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,580,474

Salary $294,211Stock awards $533,358

FY2022: $1,518,812

4th of 5 named executive officers at Korro Bio by FY2023 total.

5 named officers on file for Korro Bio, FY2023

Christopher Loose’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Korro Bio’s whole pay program stands against its peers

  • Korro Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KRRO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Christopher Loose’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Christopher Loose compensation by year

Korro Bio Summary Compensation Table · all 4 fiscal years held
In US dollars, as Korro Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2022FY2023
Salary$316,325$379,167$480,344$294,211
Bonus$55,000$0$0$0
Stock awards$0$0$604,500$533,358
Option awards$87,954$2,278,077$226,580$0
Non-equity incentive$113,750$230,000$192,138$0
Pension and deferred compensation$0$0$0$0
All other$5,105$7,271$15,250$752,905
Total$578,134$2,894,515$1,518,812$1,580,474

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Korro Bio, Inc. DEF 14A filed April 29, 2024, accession 0001193125-24-119912, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Korro Bio, Inc. filed document, accession 0001193125-24-119912. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$578K
$2.9M
$1.5M
$1.6M
FY18
FY19
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Korro Bio’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
David LucchinoFormer President and Chief Executive Officer(5)$3,878,265
Ram AiyarChief Executive Officer and President$2,858,230
Steven CollettiChief Scientific Officer(9)$1,647,368
Christopher Loose · this pageFormer Chief Scientific Officer(11)$1,580,474
Vineet AgarwalChief Financial Officer$1,322,891

The full Korro Bio compensation record

free company brief

This page is one person within Korro Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Korro Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Christopher Loose's compensation dossier · One-time report. No refunds.